Correlation Between Zhangzhou Pientzehuang and NAURA Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zhangzhou Pientzehuang and NAURA Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zhangzhou Pientzehuang and NAURA Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zhangzhou Pientzehuang Pharmaceutical and NAURA Technology Group, you can compare the effects of market volatilities on Zhangzhou Pientzehuang and NAURA Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zhangzhou Pientzehuang with a short position of NAURA Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zhangzhou Pientzehuang and NAURA Technology.

Diversification Opportunities for Zhangzhou Pientzehuang and NAURA Technology

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Zhangzhou and NAURA is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Zhangzhou Pientzehuang Pharmac and NAURA Technology Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NAURA Technology and Zhangzhou Pientzehuang is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zhangzhou Pientzehuang Pharmaceutical are associated (or correlated) with NAURA Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NAURA Technology has no effect on the direction of Zhangzhou Pientzehuang i.e., Zhangzhou Pientzehuang and NAURA Technology go up and down completely randomly.

Pair Corralation between Zhangzhou Pientzehuang and NAURA Technology

Assuming the 90 days trading horizon Zhangzhou Pientzehuang is expected to generate 4.73 times less return on investment than NAURA Technology. But when comparing it to its historical volatility, Zhangzhou Pientzehuang Pharmaceutical is 1.27 times less risky than NAURA Technology. It trades about 0.02 of its potential returns per unit of risk. NAURA Technology Group is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  29,945  in NAURA Technology Group on September 3, 2024 and sell it today you would earn a total of  11,623  from holding NAURA Technology Group or generate 38.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Zhangzhou Pientzehuang Pharmac  vs.  NAURA Technology Group

 Performance 
       Timeline  
Zhangzhou Pientzehuang 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Zhangzhou Pientzehuang Pharmaceutical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Zhangzhou Pientzehuang sustained solid returns over the last few months and may actually be approaching a breakup point.
NAURA Technology 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in NAURA Technology Group are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, NAURA Technology sustained solid returns over the last few months and may actually be approaching a breakup point.

Zhangzhou Pientzehuang and NAURA Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zhangzhou Pientzehuang and NAURA Technology

The main advantage of trading using opposite Zhangzhou Pientzehuang and NAURA Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zhangzhou Pientzehuang position performs unexpectedly, NAURA Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NAURA Technology will offset losses from the drop in NAURA Technology's long position.
The idea behind Zhangzhou Pientzehuang Pharmaceutical and NAURA Technology Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data